| 1 | regimen | 13,035 |
| 2 | regime | 903 |
| 3 | regiment | 21 |
| 4 | me-trap | 10 |
| 5 | recalculations | 4 |
| 6 | drospirenone/estradiol | 3 |
| 7 | mеldonium | 3 |
| 8 | bioscore | 2 |
| 9 | bpsp | 2 |
| 10 | pancreatic-jejunostomy | 2 |
| 11 | preamplifier | 2 |
| 12 | upa-cvr | 2 |
| 13 | 'capping | 1 |
| 14 | 19/7 | 1 |
| 15 | 2-trim | 1 |
| 16 | 20/8 | 1 |
| 17 | 3-trim | 1 |
| 18 | 4-trim | 1 |
| 19 | algorithm-medication | 1 |
| 20 | antiplatelettherapy | 1 |
| 21 | centere | 1 |
| 22 | chaperone-protease | 1 |
| 23 | colony-stimulating-factor | 1 |
| 24 | cyle | 1 |
| 25 | folfirinox-regimen | 1 |
| 26 | forschungszentrum | 1 |
| 27 | h=43.54 | 1 |
| 28 | ha1/ha | 1 |
| 29 | indication.orbec | 1 |
| 30 | iscritical | 1 |
| 31 | lists/tariff | 1 |
| 32 | nucleo | 1 |
| 33 | outcome.risperidone | 1 |
| 34 | pre-exposición | 1 |
| 35 | regimen-pi | 1 |
| 36 | regimens.there | 1 |
| 37 | retinopthy | 1 |
| 38 | strategies-cc | 1 |
| 39 | tracer- | 1 |
| 40 | ybff | 1 |
| 1 | 'capping | 1 |
| 2 | 19/7 | 1 |
| 3 | 2-trim | 1 |
| 4 | 20/8 | 1 |
| 5 | 3-trim | 1 |
| 6 | 4-trim | 1 |
| 7 | algorithm-medication | 1 |
| 8 | antiplatelettherapy | 1 |
| 9 | bioscore | 2 |
| 10 | bpsp | 2 |
| 11 | centere | 1 |
| 12 | chaperone-protease | 1 |
| 13 | colony-stimulating-factor | 1 |
| 14 | cyle | 1 |
| 15 | drospirenone/estradiol | 3 |
| 16 | folfirinox-regimen | 1 |
| 17 | forschungszentrum | 1 |
| 18 | h=43.54 | 1 |
| 19 | ha1/ha | 1 |
| 20 | indication.orbec | 1 |
| 21 | iscritical | 1 |
| 22 | lists/tariff | 1 |
| 23 | me-trap | 10 |
| 24 | mеldonium | 3 |
| 25 | nucleo | 1 |
| 26 | outcome.risperidone | 1 |
| 27 | pancreatic-jejunostomy | 2 |
| 28 | pre-exposición | 1 |
| 29 | preamplifier | 2 |
| 30 | recalculations | 4 |
| 31 | regime | 903 |
| 32 | regimen | 13,035 |
| 33 | regimen-pi | 1 |
| 34 | regimens.there | 1 |
| 35 | regiment | 21 |
| 36 | retinopthy | 1 |
| 37 | strategies-cc | 1 |
| 38 | tracer- | 1 |
| 39 | upa-cvr | 2 |
| 40 | ybff | 1 |
| 1 | tracer- | 1 |
| 2 | h=43.54 | 1 |
| 3 | 19/7 | 1 |
| 4 | 20/8 | 1 |
| 5 | ha1/ha | 1 |
| 6 | strategies-cc | 1 |
| 7 | indication.orbec | 1 |
| 8 | cyle | 1 |
| 9 | regime | 903 |
| 10 | outcome.risperidone | 1 |
| 11 | regimens.there | 1 |
| 12 | centere | 1 |
| 13 | bioscore | 2 |
| 14 | chaperone-protease | 1 |
| 15 | ybff | 1 |
| 16 | lists/tariff | 1 |
| 17 | 'capping | 1 |
| 18 | regimen-pi | 1 |
| 19 | iscritical | 1 |
| 20 | drospirenone/estradiol | 3 |
| 21 | 2-trim | 1 |
| 22 | 3-trim | 1 |
| 23 | 4-trim | 1 |
| 24 | mеldonium | 3 |
| 25 | forschungszentrum | 1 |
| 26 | regimen | 13,035 |
| 27 | folfirinox-regimen | 1 |
| 28 | algorithm-medication | 1 |
| 29 | pre-exposición | 1 |
| 30 | nucleo | 1 |
| 31 | me-trap | 10 |
| 32 | bpsp | 2 |
| 33 | preamplifier | 2 |
| 34 | colony-stimulating-factor | 1 |
| 35 | upa-cvr | 2 |
| 36 | recalculations | 4 |
| 37 | regiment | 21 |
| 38 | retinopthy | 1 |
| 39 | pancreatic-jejunostomy | 2 |
| 40 | antiplatelettherapy | 1 |